AZALACTAM COMPOUNDS AS HPK1 INHIBITORS
VE6142019000588SUndetermined Publication Date: 2022-02-17PFIZER INC
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- VE · VE
- Patent Type
- Designs
- Current Assignee / Owner
- PFIZER INC
- Filing Date
- 2019-11-14
- Publication Date
- 2022-02-17
Need to check novelty before this filing date? Find Prior Art
Description
The present invention relates to compounds of the general formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R1A, R2, R3, R4, and (R5)A are as defined herein, to pharmaceutical compositions comprising said compounds and pharmaceutically acceptable salts thereof, and to methods of use of said compounds, pharmaceutically acceptable salts thereof, and compositions for the treatment of abnormal cell growth, including cancer.